Please assess the completion status of the following clinical trial:

Trial Title: Altis® 522 Trial - Treatment of Female Stress Urinary Incontinence

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* The subject is female and at least 18 years of age.~* The subject is able and willing to complete all procedures and follow-up visits indicated in this protocol.~* The subject has confirmed stress urinary incontinence (SUI) through cough stress test or urodynamics.~* The subject has failed two non-invasive incontinence therapies (such as Kegel exercise, behavior modification, pad use, biofeedback, etc.) for \> 6 months.~Exclusion Criteria:~* The subject has an active urogenital infection or active skin infection in region of surgery.~* The subject has confirmed Pelvic Organ Prolapse (POP) of Stage 2 or higher as determined by POP-Q prolapse grading.~* The subject is having a concomitant pelvic floor procedure.~* The subject has incontinence due to neurogenic causes (e.g. multiple sclerosis, spinal cord/brain injury, cerebrovascular accident, detrusor-external sphincter dyssynergia, Parkinson's disease, or similar conditions).~* The subject had a prior surgical stress urinary incontinence (SUI) treatment.~* The subject has undergone radiation or brachy therapy to treat pelvic cancer.~* The subject has urge predominant incontinence by MESA assessment.~* The subject has an atonic bladder or post void residual (PVR) above 100 cc on ≥ 2 occasions.~* The subject is pregnant and/or is planning to get pregnant in the future.~* The subject has a contraindication to the surgical procedure or the product Instructions for Use (IFU).~* The subject is enrolled in a concurrent clinical trial of any treatment (drug or device) that could affect continence function, without the sponsors approval.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Altis arm (Type: None): Subjects will have an Altis sling placed to treat stress urinary incontinence.
- Comparator arm (Type: None): Subjects will have a transobturator or retropubic sling placed to treat stress urinary incontinence.

Based on this trial design, predict the completion outcome and termination type (if applicable).